Neovasc (NASDAQ:NVCN) (TSE:NVC) will be issuing its quarterly earnings data after the market closes on Wednesday, August 7th. Analysts expect the company to announce earnings of ($1.70) per share for the quarter.
Neovasc (NASDAQ:NVCN) (TSE:NVC) last issued its earnings results on Thursday, May 9th. The medical equipment provider reported ($0.20) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.07) by ($0.13). The business had revenue of $0.59 million for the quarter, compared to analysts’ expectations of $0.40 million. On average, analysts expect Neovasc to post $-6 EPS for the current fiscal year and $-8 EPS for the next fiscal year.
NASDAQ:NVCN traded up $0.06 during trading hours on Monday, hitting $2.83. The stock had a trading volume of 225 shares, compared to its average volume of 186,427. Neovasc has a one year low of $2.34 and a one year high of $45.80. The stock has a market cap of $20.72 million, a P/E ratio of -0.10 and a beta of 1.41. The firm has a 50 day moving average price of $2.61.
Neovasc Inc, a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products.
Featured Story: The components of the Stochastic Momentum Index
Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.